Studies have shown that decreased ACE-2 activity leads to an imbalance in the renin-angiotensin-aldosterone system (RAAS), resulting in increased levels of Ang II and subsequent vasoconstriction, oxidative stress, inflammation, and fibrosis, which are contributing factors to hypertension and heart failure. Here, ACE2 is linked to hypertensive disorder.